# Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and Fever

> **NCT07051525** · NA · RECRUITING · sponsor: **Peter MacCallum Cancer Centre, Australia** · enrollment: 214 (estimated)

## Conditions studied

- Leukemia
- CART Therapy
- Transplantation, Stem Cell
- Infections, Bacterial

## Interventions

- **DRUG:** Early antibiotic cessation alert

## Key facts

- **NCT ID:** NCT07051525
- **Lead sponsor:** Peter MacCallum Cancer Centre, Australia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-03
- **Primary completion:** 2027-12-05
- **Final completion:** 2028-02-05
- **Target enrollment:** 214 (ESTIMATED)
- **Last updated:** 2025-12-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07051525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07051525, "Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and Fever". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07051525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*